Emami accepts resignation of Company Secretary Ravi Varma effective August 31
- Emami Limited accepted the resignation of Company Secretary Ravi Varma
- The change takes effect on August 31, 2026
- Mr. Varma also steps down as the company's Nodal Officer
- Disclosure filed under SEBI Listing Regulations Regulation 30
- Mr. Varma cited professional growth as the reason for leaving

*this image is generated using AI for illustrative purposes only.
Emami Limited has accepted the resignation of Mr. Ravi Varma as Company Secretary and Compliance Officer, effective August 31, 2026. The company disclosed the change in a filing with stock exchanges on August 29, 2026.
Mr. Varma also ceases to act as the Nodal Officer of the company in compliance with Rule 7 (2A) of the Investor Education and Protection Fund Authority (Accounting, Audit, Transfer and Refund) Rules, 2016.
Regulatory Disclosure
The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
| Particulars | Details |
|---|---|
| Reason for Change | Resignation of Mr. Ravi Varma |
| Effective Date | August 31, 2026 |
| Previous Role | Company Secretary and Compliance Officer |
Resignation Details
In his resignation letter dated August 28, 2026, Mr. Varma stated he chose to explore new opportunities for professional growth outside the organisation. He confirmed there were no other reasons for his departure.
Harsh Vardhan Agarwal, Vice Chairman and Managing Director, signed the intimation letter to the exchanges.
Historical Stock Returns for Emami
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.14% | -6.87% | -8.38% | -17.99% | -33.76% | -36.40% |
Who has been appointed as the interim or permanent successor to Mr. Ravi Varma as Company Secretary and Compliance Officer?
How might this leadership change in compliance roles impact Emami's regulatory reporting timelines and investor relations during the transition period?
Are there any pending regulatory audits or compliance issues at Emami that could be influenced by this change in the Nodal Officer?


































